The ablation of FSTL3 in CRC has a promoting effect on the creation of an anti-tumor microenvironment, which is mainly characterized by the improved anti-tumor efficacy of CD8+ T cells and repressed infiltration of regulatory T cells (Tregs). This evidence concerns the gene FSTL3 and colorectal carcinoma.